Arkuda Therapeutics

📍 Watertown, United States👥 16 employees💰 Last funded Feb 2024
Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
4
Investor activity2019–2024 · investors recorded per year
2019220242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Arkuda Therapeutics?
Arkuda Therapeutics has 4 investors on record on gritt.io.
When did Arkuda Therapeutics last raise funding?
The most recent investment in Arkuda Therapeutics recorded on gritt.io was in February 2024.
What industry is Arkuda Therapeutics in?
Arkuda Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Arkuda Therapeutics based?
Arkuda Therapeutics is headquartered in Watertown, United States.